India's Pharma Industry Faces Profit Squeeze Amid Weak Rupee and Slowing Exports
Quick Look
- India's pharmaceutical sector is hit by rising import costs due to a weaker rupee and declining export demand from a global economic slowdown, squeezing manufacturer profits.
- Companies are shifting to higher-margin products to cope.
AI-generated summary
India's pharmaceutical sector is hit by rising import costs due to a weaker rupee and declining export demand from a global economic slowdown, squeezing manufacturer profits. Companies are shifting to higher-margin products to cope.